Initial Testing of a Behavioral Intervention About Genetic Services for Families at Risk of Lynch Syndrome
University of Alabama at Birmingham · with National Cancer Institute (NCI) · NCT07106359
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 185
- US sites recruiting
- 1
- Study start
- September 15, 2025
- Record last updated
- July 21, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The purpose of the study is to see if our education materials help people at risk for Lynch syndrome decide about seeking genetic services. Untested relatives of patients with Lynch syndrome will be recruited to complete a baseline survey and will be randomized to receive either the an information letter or an information letter plus a booklet. Two follow-up surveys will be administered over the span of 6 months. Participants will also be invited to join an optional exit interview to provide feedback.
Being studied: Information Letter and Booklet; Information Letter
Conditions: Cascade Testing; Lynch Syndrome; Decision Making; Colorectal Cancer; Uterine Cancer; Cancer Prevention
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Probands Inclusion Criteria
- English speaking
- at least 18 years old
- have had genetic testing for Lynch syndrome (LS)
- do not have a condition that would interfere with their ability to provide informed consent and complete study activities (e.g., cognitive dysfunction evaluated using clinical judgment during screening)
Clinical Trial Participants Inclusion Criteria:
- English-speaking
- at least 18 years old
- a blood relative of a patient who was diagnosed with LS
- potentially at risk for LS
- have not scheduled or had pre-test genetic counseling or genetic testing for LS
- do not have a personal history of a cancer (excluding non-melanoma skin cancer)
- do not have a condition that would interfere with their ability to provide informed consent and complete study activities (e.g., cognitive dysfunction evaluated using clinical judgment during screening)
Recruiting US locations
UAB
Birmingham, AL 35233
Site contact: study team · 205-914-2249 · LSPilotStudy@uabmc.edu
Study contacts (from the official record)
- Haoyang Yan, PhD · 205-914-2249 · LSPilotStudy@uabmc.edu
- Kaylee Burgan, MS · 205-914-2249 · LSPilotStudy@uabmc.edu
Similar studies in Alabama
All healthy volunteers studies in Alabama →- RecruitingHealthy volunteersPhase 1/Phase 2
A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease
Novartis Pharmaceuticals
- Location
- Birmingham, AL + 7 other US sites
- Eligibility basics
- Ages 12–55
- RecruitingHealthy volunteersPhase 1/Phase 2
Phase 1/2 Study of Respiratory Syncytial Virus and Human Metapneumovirus (RSV+HMPV) Vaccine Candidate in Adults 60 Years of Age and Older
Sanofi
- Location
- Gadsden, AL + 49 other US sites
- Eligibility basics
- Ages 60+
- RecruitingHealthy volunteersPhase 1
First-in-Human Trial to Assess REGN20423 in Healthy Adult Participants and Adult Participants With Atopic Dermatitis
Regeneron Pharmaceuticals
- Location
- Birmingham, AL + 5 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteersPhase 1
A Study of Ulonivirine (MK-8507) and Methadone in Healthy Volunteers (MK-8507-019)
Merck Sharp & Dohme LLC
- Location
- Anniston, AL
- Eligibility basics
- Ages 18–65